Jennifer Lynn Erker, DNP, APRN-C
NPI 1528527439ActiveIndividual· Nurse Practitioner, Primary Care· Goddard, KS
Opted out of Medicare from October 2022 to October 2028. Nurse Practitioner, Primary Care (DNP, APRN-C) in Goddard, Kansas, licensed in KS, with an NPI issued in March 2019. Part D covered 1,213 prescriptions written in 2024, 89% of them generic. Astrazeneca Pharmaceuticals LP was the largest of 5 companies reporting payments in 2025, $124.55 in all, mostly food and beverage.
Overview
| NPI | 1528527439 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | DNP, APRN-C |
| Sole proprietor | Yes |
| NPI issued | Mar 19, 2019 |
| Last updated in NPPES | Sep 14, 2026 |
| Certified by provider | Sep 14, 2026 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Nurse Practitioner, Primary Care Primary | 363LP2300X | 78640 | KS |
| Nurse Practitioner, Family | 363LF0000X | 78640 | KS |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Oct 1, 2022 – Oct 1, 2028 |
| Can order and refer | Yes |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Part D prescriptions in 2024
| Prescriptions (claims) | 1,213 · 2,058 30-day fills |
|---|---|
| Patients | 35 |
| Total drug cost | $136,868 |
| Generic share | 89% of claims |
Industry payments (Open Payments)
- 2025$124.55 · 7 payments from 5 companies
- 2024$123.85 · 8 payments from 3 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $47.53 | 3 |
| Abbvie Inc. | $25.21 | 1 |
| Axsome Therapeutics, Inc. | $19.22 | 1 |
| Lilly USA, LLC | $17.88 | 1 |
| Novo Nordisk Inc | $14.71 | 1 |
What the 2025 payments were for
- Food and Beverage$124.55 · 7 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records